Dalia Ercan
Impact in
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Oncology top 1%
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
Papers in
-
- Lung Cancer Treatments and Mutations 15
- Prostate Cancer Treatment and Research 1
-
- Cancer therapeutics and mechanisms 7
- Fibroblast Growth Factor Research 2
- Co-authors
- Pasi A. Jänne (18 shared papers)Nathanael S. Gray (10 shared papers)Marzia Capelletti (12 shared papers)Michael J. Eck (3 shared papers)Kwok‐Kin Wong (5 shared papers)Cai‐Hong Yun (2 shared papers)Geoffrey R. Oxnard (3 shared papers)Yanan Kuang (1 shared paper)
- Journals
- Cancer Research (6 papers)Clinical Cancer Research (3 papers)Journal of Clinical Oncology (1 paper)Molecular Oncology (1 paper)Cancers (1 paper)
- Partner nations
- United StatesSouth KoreaJapan
In The Last Decade
Dalia Ercan
19 papers receiving 3.6k citations
Dalia Ercan's Hit Papers
Peers
Comparison fields: 5 of 75
- Pulmonary and Respiratory Medicine 2.2k
- Oncology 1.7k
- Cancer Research 659
- Molecular Biology 2.0k
- Pathology and Forensic Medicine 234
Countries citing papers authored by Dalia Ercan
This map shows the geographic impact of Dalia Ercan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalia Ercan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalia Ercan more than expected).
Fields of papers citing papers by Dalia Ercan
This network shows the impact of papers produced by Dalia Ercan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalia Ercan. The network helps show where Dalia Ercan may publish in the future.
Co-authors
The 25 scholars most cited alongside Dalia Ercan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M Hit paper breakdown → | 2015 | 1200 |
| 2 | Novel mutant-selective EGFR kinase inhibitors against EGFR T790M Hit paper breakdown → | 2009 | 792 |
| 3 | EGFR Mutations and Resistance to Irreversible Pyrimidine-Based EGFR Inhibitors Hit paper breakdown → | 2015 | 293 |
| 4 | 2015 | 253 | |
| 5 | 2010 | 181 | |
| 6 | 2014 | 164 | |
| 7 | 2012 | 163 | |
| 8 | 2015 | 161 | |
| 9 | 2017 | 102 | |
| 10 | 2012 | 87 | |
| 11 | 2014 | 81 | |
| 12 | 2016 | 67 | |
| 13 | 2014 | 52 | |
| 14 | 2010 | 48 | |
| 15 | 2015 | 30 | |
| 16 | 2012 | 5 | |
| 17 | 2012 | 4 | |
| 18 | 2023 | 1 | |
| 19 | 2011 | 1 | |
| 20 | 2025 | 0 |
About Dalia Ercan
Dalia Ercan is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Organic Chemistry and Cancer Research, having authored 20 papers that have together received 3.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (15 papers), Cancer therapeutics and mechanisms (7 papers), HER2/EGFR in Cancer Research (5 papers), Cancer Genomics and Diagnostics (2 papers), Lung Cancer Research Studies (2 papers), Quinazolinone synthesis and applications (2 papers), Fibroblast Growth Factor Research (2 papers) and Prostate Cancer Treatment and Research (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.2k citations), Oncology (1.7k citations), Cancer Research (659 citations), Molecular Biology (2.0k citations) and Pathology and Forensic Medicine (234 citations). Dalia Ercan has collaborated with scholars based in United States, South Korea and Japan. Frequent co-authors include Pasi A. Jänne, Nathanael S. Gray, Marzia Capelletti, Michael J. Eck, Kwok‐Kin Wong, Cai‐Hong Yun, Geoffrey R. Oxnard, Yanan Kuang, Brian Dougherty and Ana Vivancos. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Journal of Clinical Oncology, Molecular Oncology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.